These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17329287)

  • 1. The House of Commons Health Committee: 'The Influence of the Pharmaceutical Industry'. Too much too late?
    Kerwin R
    J Psychopharmacol; 2007 Mar; 21(2):131-3. PubMed ID: 17329287
    [No Abstract]   [Full Text] [Related]  

  • 2. Marketing of antipsychotic drugs targeted doctors of Medicaid patients, report says.
    Roehr B
    BMJ; 2012 Oct; 345():e6633. PubMed ID: 23033376
    [No Abstract]   [Full Text] [Related]  

  • 3. Study affirms PhRMA's influence on physicians.
    Miller JD
    J Natl Cancer Inst; 2007 Aug; 99(15):1148-50. PubMed ID: 17652272
    [No Abstract]   [Full Text] [Related]  

  • 4. Marketing pharmaceuticals: a constitutional right to sell prescriber-identified data?
    Gostin LO
    JAMA; 2012 Feb; 307(8):787-8. PubMed ID: 22357827
    [No Abstract]   [Full Text] [Related]  

  • 5. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
    Johar K
    Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaceuticals and medical devices: business practices.
    Steiner DJ
    Issue Brief Health Policy Track Serv; 2013 Dec; ():1-36. PubMed ID: 24482889
    [No Abstract]   [Full Text] [Related]  

  • 7. [Case: bioethical disputes of the donations of the pharmaceutical companies to the health centers].
    González-González A
    Cuad Bioet; 2020; 31(103):423-427. PubMed ID: 33375807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug companies and clinical psychology.
    Baker E; Newnes C; Myatt H
    Ethical Hum Sci Serv; 2003; 5(3):247-53. PubMed ID: 15139338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond government intervention: drug companies and bioethics.
    Dresser R
    Am J Bioeth; 2002; 2(3):42-3. PubMed ID: 12230855
    [No Abstract]   [Full Text] [Related]  

  • 10. Financial incentives and the prescription of newer vaccines by doctors in India.
    Lodha R; Bhargava A
    Indian J Med Ethics; 2010; 7(1):28-30. PubMed ID: 20166294
    [No Abstract]   [Full Text] [Related]  

  • 11. Nurses and the pharmaceutical industry: part 1.
    Olsen DP
    Am J Nurs; 2009 Jan; 109(1):36-9. PubMed ID: 19112263
    [No Abstract]   [Full Text] [Related]  

  • 12. Selling drugs to doctors--it's marketing, not education.
    Cooper R; Hoffman J
    Br J Gen Pract; 2002 Feb; 52(475):168-9. PubMed ID: 11885830
    [No Abstract]   [Full Text] [Related]  

  • 13. No evidence or no alternative? Taking responsibility for off-label prescribing.
    Ghinea N; Lipworth W; Kerridge I; Day R
    Intern Med J; 2012 Mar; 42(3):247-51. PubMed ID: 22432984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. America's other drug problem: how the drug industry distorts medicine and politics.
    Relman AS; Angell M
    New Repub; 2002 Dec; 227(25):27-41. PubMed ID: 12561803
    [No Abstract]   [Full Text] [Related]  

  • 15. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
    Brand R
    State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
    [No Abstract]   [Full Text] [Related]  

  • 16. Don't ban the sunset in pharmaceutical advertising if it doesn't darken the sky.
    Huddle TS
    Am J Bioeth; 2013; 13(5):27-30. PubMed ID: 23557043
    [No Abstract]   [Full Text] [Related]  

  • 17. Internet marketing of neuroproducts: new practices and healthcare policy challenges.
    Racine E; van der Loos HZ; Illes J
    Camb Q Healthc Ethics; 2007; 16(2):181-94. PubMed ID: 17539470
    [No Abstract]   [Full Text] [Related]  

  • 18. Pharmaceutical companies: the perfect scapegoat for everything.
    Chang PL
    Am J Bioeth; 2013; 13(5):30-2. PubMed ID: 23557044
    [No Abstract]   [Full Text] [Related]  

  • 19. Response to open peer commentaries on "ban the sunset? Nonpropositional content and regulation of pharmaceutical advertising".
    Biegler P; Vargas P
    Am J Bioeth; 2013; 13(5):W1-5. PubMed ID: 23557060
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmaceutical "nudging"--reinterpreting the ethics of evaluative conditioning.
    Ploug T; Holm S
    Am J Bioeth; 2013; 13(5):25-7. PubMed ID: 23557042
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.